Noah Mckittrick, MD
Infectious Disease · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mckittrick’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Illinois 036166138Licensed Physician And Surgeon · since 2023 · expires 2026-08-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$24,307
Medicare paid this office $24,307 for 113 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $9,439 | $131 |
| Long return visit (40+ min) | 33 | $6,711 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $6,149 | $96 |
Who their Medicare patients are
113 Original Medicare patients in 2024. Average age 73 · Under 65 16% · 85 and older 12% · Women 41% · Also on Medicaid 24% · Health risk score 2.42. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 45% · Heart failure 45% · Chronic kidney disease 45% · Atrial fibrillation 44% · Coronary heart disease 43% · Depression 36% · COPD 25% · Cancer 19% · Dementia 18% · Stroke 15%.
The office billed $103,050, Medicare allowed $31,578 and paid $24,307; for 199 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 113 | 199 | 73 | 2.42 | $103,050 | $24,307 |
| 2023 | 67 | 109 | 73 | 3.05 | $46,553 | $12,638 |
| 2022 | 39 | 61 | 68 | 3.64 | $19,807 | $6,463 |
| 2021 | 36 | 55 | 66 | 2.36 | $19,262 | $6,461 |
| 2020 | 33 | 48 | 66 | 2.70 | $16,222 | $5,883 |
| 2019 | 182 | 336 | 69 | 3.80 | $124,808 | $38,020 |
| 2018 | 229 | 458 | 69 | 3.43 | $150,134 | $46,042 |
| 2017 | 43 | 59 | 69 | 3.25 | $19,667 | $6,165 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $5,561 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,421 | $95 |
2022: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,051 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,959 | $82 |
2021: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,778 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,204 | $85 |
2020: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,723 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,485 | $87 |
2019: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $15,429 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $10,592 | $87 |
| Long return visit (40+ min) | 70 | $8,514 | $88 |
| New patient visit (60+ min) | 12 | $1,736 | $145 |
2018: 8 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $12,467 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $10,460 | $88 |
| Long return visit (40+ min) | 59 | $7,114 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,735 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,685 | $61 |
| New patient visit (60+ min) | 12 | $1,715 | $143 |
| Return visit (30+ min) | 23 | $1,664 | $64 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,035 | $80 |
2017: 1 service
| Return visit (30+ min) | 11 | $855 | $66 |
Medicaid work
$958 in 2024
Medicaid paid $958 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 12 | $958 |
| 2024 | 12 | 1 | 12 | $958 |
| 2018 | 26 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 26 | $0 |
Drugs they prescribed that Part D paid
$23,721
Pharmacies billed $23,721 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 140) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
136 generic and fewer than 11 brand-name prescriptions · $23,721 in drug cost · 118 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fosfomycin Tromethamine | 12 | $3,007 | $251 |
| Ceftriaxone | 12 | $942 | $79 |
| Doxycycline Monohydrate | 24 | $247 | $10 |
Year by year
| 2024 | 140 | 48 | 0% (0) | None | $23,721 |
| 2023 | 41 | 15 | 0% (0) | 0% | $7,388 |
| 2022 | 21 | None | 0% (0) | 0% | $471 |
| 2020 | 31 | None | 0% (0) | 0% | $3,251 |
| 2019 | 101 | 31 | 0% (0) | 29% | $551,705 |
| 2018 | 85 | 31 | None | 38% | $392,537 |
| 2014 | 55 | 13 | 0% (0) | None | $1,883 |
| 2013 | 92 | 32 | 0% (0) | None | $4,660 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Ceftriaxone | 11 | $217 | $20 |
2019: 2 drugs
| Harvoni | 11 | $369,104 | $33,555 |
| Cefaclor | 11 | $504 | $46 |
2018: 1 drug
| Genvoya | 11 | $47,163 | $4,288 |
2013: 1 drug
| Metoprolol | 11 | $236 | $21 |
Money from drug and device companies
$15 in 2025
A payment is not proof that care is biased.
| Insmed | Arikayce | $15 | 1 payment
|
See the published payment
| Insmed | Meals · 2025-10-02 | Arikayce | $15 |
Professional record
- NPI
- 1902197312
- Licence
- IL 036166138, OR MD195130Illinois 036166138: Active
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-04-20
- NPI last updated
- 2025-07-21
- NPI record certified
- 2025-07-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1302 Franklin Ave Ste 3500, Normal, IL, 61761 · 3181 Sw Sam Jackson Park Rd # L457, Portland, OR, 97239